Exklusiver Live-Stream direkt von der World of Trading - 2 Tage mit einzigartigen Themen und Experten. Kostenlos teilnehmen + Videos erhalten. -w-
09.04.2013 18:00:00

Cegedim Relationship Management 2013 US Aggregate Spend Study Discovers that 89% of Respondents Anticipate Utilization of an Automated Reporting Solution for Sunshine Act Compliance

Cegedim Relationship Management, a technology information services company delivering innovation to help transform commercial and compliance operations in US healthcare, today released its fourth annual industry report, 2013 US Trends in Aggregate Spend and Disclosure Reporting. The newest US trend report displays a snapshot of how increased transparency is affecting US pharmaceutical, biotech, and medical device industries. According to the survey, Life Sciences executives indicate a projected increase in automated reporting and decreased usage of internal and manual reporting methods resulting from preparations for the finalized Sunshine Act.

Optimizing Transparency Reporting Solutions in the Face of Final Sunshine Requirements

This year, the Sunshine Act drives many Life Sciences companies to assess their systems’ ability to maintain transparency reporting compliance. An overwhelming majority (89%) of respondents expect to satisfy disclosure laws using internal or third party-based solutions as more legislative requirements are implemented. Additionally, companies reveal that manual reporting with spreadsheets is down, 40% in 2012 to 20% in 2013, in anticipation of final federal regulations.

Moreover, of the 20% of respondents using manual spreadsheets to satisfy compliance requirements, 86% plan to move to an automated solution in response to the federal law. Respondents’ top concern (50%) in anticipation of the Sunshine Act is having accurate, complete and timely data. In fact, 67% of respondents prefer their aggregate spend solution to be pre-integrated with a comprehensive customer data solution.

Global Implications of US Companies Maintaining Transparency

As transparency regulations populate both Europe and Asia-Pacific, respondents illustrate that they are taking new action. Over half (50%) specify that they have already implemented a global solution for aggregate spend and transparency reporting, up dramatically from 8% in 2012. This year’s respondents indicate their priorities for non-US transparency compliance to be Western Europe (46%) and Asia Pacific (25%) – with the highest priorities being France, UK, Germany and China.

"The finalized rule of the Sunshine Act compels companies to reflect on whether or not their current compliance practices can meet new regulations and generate value,” said Bill Buzzeo, SVP of Business Development for Cegedim Relationship Management. "With the upsurge in global transparency laws, companies must adopt a holistic compliance approach that leverages next generation technology, optimal data management, and is powered by a team of industry experts.”

Please click here to access the full survey report.

Also available: 2012 European Trends in Aggregate Spend, Transparency and Disclosure.

About Cegedim Relationship Management:      

Cegedim Relationship Management is the Life Sciences industry’s leading provider of Customer Relationship Management (CRM) solutions. Designed specifically for Life Sciences, the company’s innovative business solutions incorporate a thorough understanding of local, regional and worldwide trends. Cegedim Relationship Management enables more than 200,000 users in many of the world’s most innovative companies to stay ahead of market challenges. In addition to CRM, Cegedim Relationship Management also provides marketing, data optimization and regulatory compliance solutions in more than 80 countries. Cegedim Relationship Management is part of the France-based Cegedim S.A. Group.

To learn more, please visit: www.cegedim.com/rm.

 

 
About Cegedim:

Founded in 1969, Cegedim is a global technology and services company specializing in the healthcare field. Cegedim supplies services, technological tools, specialized software, data flow management services and databases. Its offerings are targeted notably at healthcare industries, life sciences companies, healthcare professionals and insurance companies. The world leader in life sciences CRM, Cegedim is also one of the leading suppliers of strategic healthcare industry data. Cegedim employs 8,100 people in more than 80 countries and generated revenue of €922 million in 2012. Cegedim SA is listed in Paris (EURONEXT: CGM).
To learn more, please visit: www.cegedim.com.

And follow Cegedim on Twitter: @CegedimGroup.

JETZT DEVISEN-CFDS MIT BIS ZU HEBEL 30 HANDELN
Handeln Sie Devisen-CFDs mit kleinen Spreads. Mit nur 100 € können Sie mit der Wirkung von 3.000 Euro Kapital handeln.
82% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren.
Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Indizes in diesem Artikel